|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 493/10 | (2006.01) |
| C07D 213/81 | (2013.01) | ||
| C07D 495/04 | (2006.01) | ||
| C07D 231/12 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| C07D 401/04 | (2013.01) | ||
| C07D 401/12 | (2013.01) | ||
| C07D 405/12 | (2013.01) | ||
| C07D 413/12 | (2013.01) | ||
| C07D 487/04 | (2013.01) | ||
| C07D 513/04 | (2013.01) | ||
| C07D 211/26 | (2013.01) | ||
| C07D 213/56 | (2013.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/10 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3532479 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17863621.3 |
| Date of filing the European patent application | 2017-10-24 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/058071 |
| Date | 2017-10-24 |
| (87) | Number | WO 2018/081108 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662411908 P | 2016-10-24 | US |
| (72) |
WANG, Tong , US
GATELY, Stephen , US
|
| (73) |
Translational Drug Development, LLC ,
13208 East Shea Boulevard
Suite 100, Scottsdale, Arizona 85259,
US
|
| (54) | AMIDE COMPOUNDS AS KINASE INHIBITORS |
| AMIDE COMPOUNDS AS KINASE INHIBITORS |